[Source: GenomeWeb News] – Roche announced today that its Roche NimbleGen business will collaborate with High Throughput Genomics on gene expression applications.
Under the pact, Roche NimbleGen will provide HTG with high-density, multiplex DNA microarray slides. HTG will apply its quantitative nuclease protection assay process to the arrays to enable researchers to rapidly measure gene expression levels in a variety of sample types.
The firms said that sample preparation using the qNPA technology enables simpler and more cost-effective workflow compared to traditional labeling methods.
For more information: Roche, HTG Partner on Gene Expression Technologies